---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-088225"
form_type: "8-K"
ticker: "CPRX"
cik: "0001369568"
company_name: "CATALYST PHARMACEUTICALS, INC."
filed_at: "2023-03-31T23:59:59+00:00"
generated_at: "2026-06-17T07:40:52.279722+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Catalyst Pharmaceuticals board member Philip H. Coelho to retire at 2023 annual meeting

## Summary
- Philip H. Coelho, independent director since 2002, will not stand for reelection.
- Coelho serves as Chair of Nominating/Corporate Governance Committee and on Audit Committee.
- Retirement is not due to any disagreement with the company.
- He will continue as director until term expires at the 2023 annual meeting.

## SEC filing metadata
- accession: 0001193125-23-088225
- form_type: 8-K
- ticker: CPRX
- cik: 0001369568
- company_name: CATALYST PHARMACEUTICALS, INC.
- filed_at: 2023-03-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/0001193125-23-088225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/d469581d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-088225
- JSON: https://secwatch.observer/filing/0001193125-23-088225.json
- Plain text: https://secwatch.observer/filing/0001193125-23-088225.txt

## Key facts
- Executive change
  Philip H. Coelho retired as Director at CATALYST PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Director
  source text: On March 29, 2023, Philip H. Coelho, an independent member of the Board of Directors (“Board”) of Catalyst Pharmaceuticals, Inc. (the “Company”), advised the Company of his decision not to stand for reelection at the 2023 annual meeting of the Company’s stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1369568/000119312523088225/0001193125-23-088225-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.